Although hypophosphatemia is relatively uncommon, it may be seen in anywher
e from 20% to 80% of patients who present to the ED with alcoholic emergenc
ies, diabetic ketoacidosis (DKA), and sepsis, Severe hypophosphatemia, as d
efined by a serum level below 1.0 mg/dL, may cause acute respiratory failur
e, myocardial depression, or seizures. Because hypophosphatemia is not as o
ften treated by ED physicians, becoming familiar with a single intravenous
phosphate solution and specific guidelines for phosphate repletion are esse
ntial. One mt of the most commonly available phosphate solution (K2PO4) con
tains 4.4 meg of potassium and 3 mmol (93 mgs) of phosphate. Administering
K2PO4 at a rate Of 1 mt per hour is almost always a very safe and appropria
te treatment for hypophosphatemia, This article provides guidelines for pho
sphate therapy in hypophosphatemic ED patients including those in DKA, thos
e presenting with alcohol-related complaints including alcoholic ketoacidos
is and patients with acute excerbation of asthma and chronic obstructive pu
lmonary disease.